Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Unexpected results from a study of gene therapy for rheumatoid arthritis

April 21, 1998

COX-2 inhibitors claimed by AHP for arthritis, cancer and AD

April 20, 1998

Novel cell adhesion inhibitors discovered at Biogen

April 20, 1998

AnorMED seeks licensing partner for phase II rheumatoid arthritis drug

April 17, 1998

Pfizer presents new inhibitors of MMPs and/or TNF production

April 15, 1998

New COX-2-selective compounds in development at Merck Frosst

April 9, 1998

Aspartame has potent antiarthritic activity in preclinical models and arthritic subjects

April 8, 1998

Celtrix reports interim results of phase II clinical study of SomatoKine

April 8, 1998

HMR files for European, American approval of arthritis drug

April 7, 1998

Inhibitors of MMP enzymes synthesized at American Cyanamid

April 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...